PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
46.92
ESG score below 80% of RVPH's 63.02. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
27.98
Environmental score below 80% of RVPH's 70.36. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
55.48
Similar social score to RVPH's 54.02. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
57.30
Governance score 80-90% of RVPH's 64.69. Walter Schloss would scrutinize management accountability and board independence.